Sitagliptin DIABETES » DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS INDICATION Type 2 diabetes mellitus. DOSAGE AND ADMINISTRATION The recommended dose of Janvia (Sitagliptin) is 100 mg once daily. Janvia can be taken with or without food. Patients with Renal Insufficiency. For patients with mild renal insufficiency, no dosage adjustment for Janvia (Sitagliptin) is required. For patients with […]
Generic Name: SitagliptinDosage Form: TabletsTG Name: Endocrine & Diabetes What is Glipita?Glipita is the preparation of Sitagliptin. Sitagliptin is a new oral agent approved by the USFDA to treat type 2 diabetes with diet & exercise. It belongs to a new class of antihyperglycemic, Dipeptidyl Dipeptidase-4 (DPP-4) inhibitors. This unique class of orally active agent targets the underlying […]
SitagliptinDPP-4 Inhibitor (Antidiabetic Preparations) Indication: Management of type 2 diabetes mellitus. Dosage & Administration: The recommended dose of Siglita™ is 100 mg once daily. Siglita™ can be taken with or without food.For patients with mild renal insufficiency (creatinine clearance [CrCl] 50 mL/min) no dosage adjustment for Siglita™ is required.For patients with moderate renal insufficiency (CrCl 30 to <50 […]